Talis Biomedical Corp.
(NASDAQ : TLIS)

( )
TLIS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.11%446.361.0%$804.90m
MDTMedtronic Plc 2.53%118.190.6%$589.76m
ABTAbbott Laboratories 1.08%117.260.8%$518.80m
DHRDanaher Corp. 1.91%218.500.7%$470.31m
BSXBoston Scientific Corp. 4.22%39.531.0%$421.13m
ISRGIntuitive Surgical, Inc. 0.59%713.372.3%$391.71m
ALGNAlign Technology, Inc. 3.08%536.466.3%$350.50m
BDXBecton, Dickinson & Co. 2.36%246.561.0%$349.34m
SYKStryker Corp. 1.90%240.271.3%$311.59m
DXCMDexCom, Inc. 2.20%364.097.8%$290.56m
EYESSecond Sight Medical Products, Inc. 304.90%5.7917.7%$272.48m
IDXXIDEXX Laboratories, Inc. 2.85%499.703.8%$268.01m
BAXBaxter International, Inc. 2.21%78.111.8%$230.39m
ZBHZimmer Biomet Holdings, Inc. 1.37%158.391.7%$224.78m
AAgilent Technologies, Inc. 1.02%116.161.6%$216.12m

Company Profile

Talis Biomedical Corp. develops and commercialize innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Menlo Park, CA.